180 related articles for article (PubMed ID: 23774804)
1. [Stage distribution of malignant melanomas in a Hungarian centre].
Tóth V; Somlai B; Hársing J; Hatvani Z; Kárpáti S
Orv Hetil; 2013 Jun; 154(25):969-76. PubMed ID: 23774804
[TBL] [Abstract][Full Text] [Related]
2. [Necessity of the development of a melanoma prevention program in Hungary - in the light of epidemiological data].
Tóth V
Magy Onkol; 2016 Mar; 60(1):78-83. PubMed ID: 26934355
[TBL] [Abstract][Full Text] [Related]
3. Incidence and survival in patients with cutaneous melanoma by morphology, anatomical site and TNM stage: a Danish Population-based Register Study 1989-2011.
Bay C; Kejs AM; Storm HH; Engholm G
Cancer Epidemiol; 2015 Feb; 39(1):1-7. PubMed ID: 25468643
[TBL] [Abstract][Full Text] [Related]
4. [Epidemiology of malignant melanoma (Clinical experience at the National Institute of Oncology in Hungary)].
Balatoni T; Liszkay G; Miklós Z; Kásler M
Orv Hetil; 2011 Jun; 152(25):1000-6. PubMed ID: 21642052
[TBL] [Abstract][Full Text] [Related]
5. Monitoring stage-specific trends in melanoma incidence across Europe reveals the need for more complete information on diagnostic characteristics.
de Vries E; Bray FI; Eggermont AM; Coebergh JW;
Eur J Cancer Prev; 2004 Oct; 13(5):387-95. PubMed ID: 15452451
[TBL] [Abstract][Full Text] [Related]
6. Early detection of thick melanomas in the United States: beware of the nodular subtype.
Demierre MF; Chung C; Miller DR; Geller AC
Arch Dermatol; 2005 Jun; 141(6):745-50. PubMed ID: 15967921
[TBL] [Abstract][Full Text] [Related]
7. Clinical stages of cutaneous malignant melanoma in Bulgaria.
Troyanova P; Valerianova Z; Danon S
Neoplasma; 2000; 47(4):257-60. PubMed ID: 11043833
[TBL] [Abstract][Full Text] [Related]
8. The burden of malignant melanoma--lessons to be learned from Austria.
Monshi B; Vujic M; Kivaranovic D; Sesti A; Oberaigner W; Vujic I; Ortiz-Urda S; Posch C; Feichtinger H; Hackl M; Rappersberger K
Eur J Cancer; 2016 Mar; 56():45-53. PubMed ID: 26802530
[TBL] [Abstract][Full Text] [Related]
9. Variation in incidence and fatality of melanoma by season of diagnosis in new South Wales, Australia.
Boniol M; Armstrong BK; Doré JF
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):524-6. PubMed ID: 16537711
[TBL] [Abstract][Full Text] [Related]
10. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
Buettner PG; Leiter U; Eigentler TK; Garbe C
Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
[TBL] [Abstract][Full Text] [Related]
11. Time trends and latitudinal differences in melanoma thickness distribution in Australia, 1990-2006.
Baade P; Meng X; Youlden D; Aitken J; Youl P
Int J Cancer; 2012 Jan; 130(1):170-8. PubMed ID: 21344376
[TBL] [Abstract][Full Text] [Related]
12. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society.
Chang AE; Karnell LH; Menck HR
Cancer; 1998 Oct; 83(8):1664-78. PubMed ID: 9781962
[TBL] [Abstract][Full Text] [Related]
13. Incidence of new primary melanomas after diagnosis of stage III and IV melanoma.
Zimmer L; Haydu LE; Menzies AM; Scolyer RA; Kefford RF; Thompson JF; Schadendorf D; Long GV
J Clin Oncol; 2014 Mar; 32(8):816-23. PubMed ID: 24297954
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study.
Thomas NE; Kricker A; Waxweiler WT; Dillon PM; Busman KJ; From L; Groben PA; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Venn A; Kanetsky PA; Orlow I; Paine S; Ollila DW; Reiner AS; Luo L; Hao H; Frank JS; Begg CB; Berwick M;
JAMA Dermatol; 2014 Dec; 150(12):1306-314. PubMed ID: 25162299
[TBL] [Abstract][Full Text] [Related]
15. Lower incidence rates but thicker melanomas in Eastern Europe before 1992: a comparison with Western Europe.
de Vries E; Boniol M; Doré JF; Coebergh JW;
Eur J Cancer; 2004 May; 40(7):1045-52. PubMed ID: 15093581
[TBL] [Abstract][Full Text] [Related]
16. Updated statistical data for malignant melanoma in Japan.
Ishihara K; Saida T; Yamamoto A;
Int J Clin Oncol; 2001 Jun; 6(3):109-16. PubMed ID: 11706778
[TBL] [Abstract][Full Text] [Related]
17. Trends in incidence and survival of cutaneous malignant melanoma in Estonia: a population-based study.
Padrik P; Valter A; Valter E; Baburin A; Innos K
Acta Oncol; 2017 Jan; 56(1):52-58. PubMed ID: 27796149
[TBL] [Abstract][Full Text] [Related]
18. [Clinical epidemiologic data of malignant melanoma based on 1,368 patients of the Graz University Dermatology Clinic (1970-1989)].
Rieger E; Soyer HP; Kofler R; Hödl S; Smolle J; Richtig E; Kerl H
Wien Klin Wochenschr; 1991; 103(20):612-6. PubMed ID: 1763507
[TBL] [Abstract][Full Text] [Related]
19. Increasing time trends of thin melanomas in The Netherlands: What are the explanations of recent accelerations?
van der Leest RJ; Zoutendijk J; Nijsten T; Mooi WJ; van der Rhee JI; de Vries E; Hollestein LM
Eur J Cancer; 2015 Dec; 51(18):2833-41. PubMed ID: 26589973
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for cutaneous malignant melanoma in Vaud, Switzerland.
Levi F; Randimbison L; La Vecchia C; Te VC; Franceschi S
Int J Cancer; 1998 Oct; 78(3):315-9. PubMed ID: 9766565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
